Top for 24 hours
Senate Republicans seek probe of Mylan EpiPen oversight
NEW YORK (Reuters) - Mylan NV faced new scrutiny over price hikes for its anti-allergy EpiPen on Tuesday, with U.S. lawmakers calling for a probe of oversight of the company’s rebates to government healthcare plans, while West Virginia said it was investigating whether Mylan defrauded its Medicaid department.
|Related: "Senate Republicans seek probe of Mylan EpiPen oversight" ↓|
|Last News ↓|